Anti-DLL4 x Anti-VEGF Bispecific Antibody (IgG-IgG) (BSIG-149)

Anti-DLL4 x Anti-VEGF Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-DLL4 and anti-VEGF parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Solid tumors therapy.

Datasheet INQUIRY

Specifications

Targets

DLL4 & VEGF

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Solid tumors

Targets

Target 1

DLL4

Gene ID

54567

UniProt ID

Q9NR61

Alternative Names

DLL4; delta-like 4 (Drosophila); hdelta2; delta-like protein 4; delta like canonical Notch ligand 4; delta4; delta 4; delta ligand 4; notch ligand DLL4; delta-like 4 homolog; delta-like 4 protein; notch ligand delta-2; drosophila Delta homolog 4

Target 2

VEGF

Gene ID

7422

UniProt ID

P15692

Alternative Names

VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-DLL4 x Anti-VEGF Bispecific Antibody (IgG-IgG) (BSIG-149). Click the button below to contact us or submit your feedback about this product.

Anti-DLL4 x Anti-VEGF Bispecific Antibody (IgG-IgG) (CAT#: BSIG-149)

Specifications

Targets

Customer Reviews and Q&As